Olanzapine短效型針劑於失智症病人的誘發癲癇：案例報告

Short-acting Intra-muscular Olanzapine-induced Seizure in a Patient with Dementia: A Case Report

A 69-year-old married woman patient with a three-year history of both Parkinson’s disease and Alzheimer’s disease. She had no pre-existing seizure disorder or history of head trauma. She had received amantadine 100 mg three times daily and the combined drugs of levodopa/benserazide (Madopar®) 125 mg three times daily for two years. At age of 67 years, she fi rst visited our clinic presenting herself with psychotic symptoms including persecutory delusion, and the delusion of personal belongings being stolen. The result of neurological examinations revealed no focal sign of the brain. At that time, she received 50 mg of quetiapine per day at bedtime.